CT perfusion in hepatocellular carcinoma: Is it reliable?

Ninety percent of hepatic cancers are hepatocellular carcinomas (HCC) which have an unfavorable prognosis. HCC is a hypervascular tumor supplied mainly by the hepatic artery. It has a higher blood supply than the surrounding hepatic tissue due to neovascularization. Computed tomography with perfusio...

Full description

Saved in:
Bibliographic Details
Published inEgyptian journal of radiology and nuclear medicine Vol. 48; no. 4; pp. 791 - 798
Main Authors Hatem Shalaby, Mennatallah, Ali Shehata, Khaled A.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.12.2017
SpringerOpen
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ninety percent of hepatic cancers are hepatocellular carcinomas (HCC) which have an unfavorable prognosis. HCC is a hypervascular tumor supplied mainly by the hepatic artery. It has a higher blood supply than the surrounding hepatic tissue due to neovascularization. Computed tomography with perfusion imaging (CTP) is a non invasive tool which quantifies the blood flow parameters of HCC and compares it to the surrounding tissue. To prove that CTP is a valuable diagnostic tool in diagnosis of HCC and posttherapeutic assessment. One hundred and twenty-six HCC patients with 150 focal lesions are enrolled this study. Perfusion parameters are quantified and results are compared to those of triphasic CT. CTP detected 141 lesions with 94% sensitivity and 40% specificity with elevated arterial perfusion (AP) and perfusion index (PI) with low portal flow (PF). It missed 5 lesions because of their hypovascularity and 4 lesions following radiofrequency ablation (RFA) and trans arterial chemo embolization (TACE). CTP is a safe and specific imaging tool for diagnosis and assessment of therapeutic interventional procedures in HCC.
ISSN:0378-603X
DOI:10.1016/j.ejrnm.2017.07.013